Skip to main content
Agfa-Gevaert NV logo

Agfa-Gevaert NV — Investor Relations & Filings

Ticker · AGFB ISIN · BE0003755692 LEI · 549300IHBDUTUNQJJB79 BR Manufacturing
Open in API
Filings indexed 771 across all filing types
Latest filing 2023-03-08 Interim / Quarterly Rep…
Country BE Belgium
Listing BR AGFB

About Agfa-Gevaert NV

https://www.agfa.com/corporate/

Agfa-Gevaert NV is a multinational corporation that develops, manufactures, and distributes a range of analog and digital imaging systems and IT solutions. The company's activities are concentrated in several divisions. The HealthCare IT division provides integrated solutions for medical imaging and information management, including its Enterprise Imaging platform which utilizes artificial intelligence. The Digital Print & Chemicals division supplies the graphics industry with products such as large-format inkjet printers, inks, software, and synthetic papers. The Specialty Products division develops advanced materials, including high-performance films and membranes for various industrial applications, such as the production of green hydrogen. The company leverages its extensive experience in imaging technology to deliver innovative solutions to professional and industrial markets.

Recent filings

Filing Released Lang Actions
CO_20230308_Q4_NL statements.pdf
Interim / Quarterly Report Classification · 100% confidence The document contains detailed consolidated financial statements, including profit and loss accounts and comprehensive income statements for both the full year and the fourth quarter. It provides specific financial data (revenue, EBIT, net profit, etc.) for 2021 and 2022. Since it contains substantive financial statements for a period shorter than a full fiscal year (Q4) and the full year, it qualifies as an Interim/Quarterly Report (IR). Q4 2022
2023-03-08 Dutch
CO_20230308_Q4_UK final .pdf
Earnings Release Classification · 98% confidence The document is titled "The Agfa-Gevaert Group in full year 2022" and contains detailed financial tables comparing Fiscal Year (FY) 2022 results against FY 2021, including Revenue, Adjusted EBITDA, Net Result, and segment performance. It also includes a CEO commentary and an outlook for 2023. The content is comprehensive, covering the entire fiscal year's performance, which is the defining characteristic of an Annual Report (10-K). Although it is presented as a press release summarizing the results, the depth and scope of the financial data strongly indicate it is the primary disclosure accompanying the full annual filing, which maps best to the '10-K' category for comprehensive annual performance review, rather than just an 'ER' (Earnings Release) which is typically quarterly and less detailed, or an 'IR' (Interim Report) which is for shorter periods. Given the context of a major global corporate filing database, this detailed annual summary aligns with the 10-K disclosure. FY 2022
2023-03-08 English
CO_20230308_Q4_NL final.pdf
Earnings Release Classification · 98% confidence The document is titled "PERSBERICHT" (Press Release) and explicitly states it discusses the "volledig jaar 2022" (full year 2022) results of the Agfa-Gevaert Groep, dated March 8, 2023. It contains detailed financial tables comparing FY 2022 results against FY 2021, covering revenue, adjusted EBITDA, net loss, and outlook for 2023. This structure—a summary announcement of comprehensive annual financial performance, including key figures and management commentary—is characteristic of an Earnings Release (ER) or a preliminary announcement preceding the full 10-K filing. Since it provides the core financial highlights and commentary for the full year, it fits the definition of an Earnings Release (ER) best, as it is the initial announcement of the period's results, even though it is quite detailed. It is not the full 10-K, nor is it a transcript or a short announcement of a report (RPA/RNS). FY 2022
2023-03-08 Dutch
CO_20221109_Q3_UK_statements.pdf
Interim / Quarterly Report Classification · 100% confidence The document contains detailed, unaudited consolidated financial statements, including the Statement of Profit or Loss, Statement of Comprehensive Income, Statement of Financial Position, and Statement of Cash Flows for the Q3 and 9M periods ending September 2022. Since it provides substantive financial data for an interim period rather than just an announcement or summary, it is classified as an Interim/Quarterly Report. 9M 2022
2022-11-09 English
CO_20221109_Q3_NL_statements.pdf
Interim / Quarterly Report Classification · 100% confidence The document contains detailed consolidated financial statements, including profit and loss accounts and comprehensive income statements for the third quarter (Q3) and the first nine months (9M) of 2022 compared to 2021. It provides substantive financial data rather than just a summary or announcement. Given the reporting period is less than a full fiscal year and it contains actual financial statements, it is classified as an Interim/Quarterly Report. 9M 2022
2022-11-09 Dutch
CO_20221109_Q3_UK final.pdf
Earnings Release Classification · 100% confidence The document is explicitly titled as a "PRESS RELEASE" and begins with the date and the heading "The Agfa-Gevaert Group in Q3 2022:". It provides key financial highlights (Adjusted EBITDA, revenue changes) and a CEO commentary on the third quarter results, followed by detailed segment performance tables for Q3 2022 compared to Q3 2021, and an outlook section. This structure is characteristic of an Earnings Release (ER), which announces periodical financial results (key highlights). It is not the comprehensive Annual Report (10-K) or a full Interim/Quarterly Report (IR), as it focuses on the immediate release of results rather than being a full statutory filing. Since the document is a press release announcing the results, the appropriate code is ER. Q3 2022
2022-11-09 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.